Table 7 Treatment and outcome - Entities occurring at all ages (B), continues table 6
From: Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany
Patient No. | Mechanical ventilation | Surfactant treatment, response | O2 supply at rest | Immuno-suppressive treatment | Response to treatment | Long term out-come** |
|---|---|---|---|---|---|---|
22 | No | n.k. | n.k. | n.k. | ||
23 | No | n.k. | Systemic steroids | good | alive | |
24 | No | no | Systemic steroids | good | n.k. | |
25 | No | n.k. | Systemic steroids | good | alive | |
26 | No | n.k. | no | Systemic steroids | good | alive |
27 | No | n.k. | 0.5-1 l/min | Systemic steroids | good | alive |
28 | No | no | Systemic steroids | good | alive | |
29 | No | no | 1-2 l/min | Systemic steroids | good | alive |
30 | No | no | 2 l/min | No steroids, allergen removal | good | alive |
31 | No | n.k. | no | No steroids, allergen removal | good | alive |
32 | No | no | Systemic steroids | good | alive | |
33 | No | no | Systemic steroids | good | alive | |
34 | No | n.k. | Systemic steroids | good | alive | |
35 | No | n.k. | Systemic steroids | good | alive | |
36 | No | no | Systemic steroids | good | n.k. | |
37 | No | n.k. | 0,3 l/min | n.k. | n.k. | |
38 | n.k. | n.k. | no | n.k. | n.k. |